PExA AB (publ) (FA0.F)

0.0302 +0.0022 (+7.86%) At close: 03:29PM CEST

PExA AB (publ)

Arvid Wallgrens Backe 20
Gothenburg 413 46
Sweden
46 7 05 86 43 80
https://pexa.se

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Tomas Gustafsson	MD & CEO	N/A	N/A	1971
Ms. Anna-Carin Olin	Founder, Research Director & Director	N/A	N/A	1960

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

PExA AB (publ) develops and commercializes diagnostic products in various respiratory diseases, such as asthma, tuberculosis, cystic fibrosis, lung cancer, chronic airway inflammation, and chronic obstructive pulmonary diseases. Its research instrument helps lung researchers in the collection of microscopic particles and biomarkers for diseases in the small airways. The company offers PExA 2.0, an instrument for the non-invasive collection of particles in exhaled air. It also provides accessories, which includes substrate surfaces and nozzles, parts, and service kits, as well as support services. The company provides its products for lung research centers within the health services, academia, and pharmaceutical companies. PExA AB (publ) has a research collaboration agreement with Janssen Research & Development, LLC and the University of Gothenburg for the discovery of biomarkers in exhaled air. The company was founded in 2004 and is based in Gothenburg, Sweden.

Corporate governance

PExA AB (publ)’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.